ReachRxResearch
Home
Research
Sign Up
Relationship between Antibiotic Prescription and Survival in Hospice
Back to Research Hub
  1. Home
  2. Research Hub
  3. Relationship between Antibiotic Prescrip…

Relationship between Antibiotic Prescription and Survival in Hospice

Clinical Infectious Diseases·September 11Open Access
Infectious DiseasesPractice changingCancerInfectious DiseaseTerminal IllnessRetrospective Cohort StudyAntibiotic TherapyMixed

Summary

View source

What was studied

This retrospective cohort study evaluated the association between antibiotic prescribing and survival in 6,169 outpatient hospice patients enrolled between June 2017 and January 2023, using time-dependent Cox proportional hazards models adjusted for age, sex, Charlson Comorbidity Index, and hospice-qualifying condition (HQC).

Key findings

Antibiotic use was associated with **increased hazard of death** overall (aHR 1.47; 95% CI 1.37–1.57). The effect was strongest in patients with cancer HQCs (aHR 1.67; 95% CI 1.50–1.87). A survival benefit was seen only in patients with infectious HQCs (aHR 0.60; 95% CI 0.40–0.89). Median time to first antibiotic prescription was 16 days post-enrollment (IQR 3–83).

Study limitations

- Observational design cannot confirm causality; increased mortality may reflect confounding by indication (sicker patients more likely to receive antibiotics). - No data on symptom burden, functional status, or whether antibiotics were prescribed for comfort vs. life-prolonging intent. - Single health system limits generalizability.

Clinical implications

For most hospice patients — especially those with cancer — antibiotics are unlikely to prolong life and the symptom burden prompting their use may reflect the dying process itself. Clinicians should counsel patients and families that antibiotics rarely extend survival in this setting, reserving use for those with a clear infectious HQC where a modest benefit was observed.

Caveats

  • Study is from a single large health system; prescribing culture and patient population may not be broadly representative.
  • The increased hazard of death associated with antibiotic use is highly susceptible to confounding by indication — patients who are closer to death may be more likely to receive antibiotics for perceived infections. The authors acknowledge this but cannot fully exclude it with available data.
  • The 'infectious HQC' subgroup showing a survival benefit (aHR 0.60) is relatively small; wide confidence intervals (0.40–0.89) warrant cautious interpretation.

Related Questions

Explore related topics

Do antibiotics improve comfort or quality of life in hospice patients?How should clinicians counsel hospice patients about antibiotic use near end of life?What is the role of antimicrobial stewardship in palliative and hospice care?

Publication Details

Year
2026
Journal
Clinical Infectious Diseases
Sample Size
n=6,169
Source
View article
Keep scrolling
More content below.
Up Next